EligibleTrials

Clinical trials recruiting for Angiosarcoma

4
Recruiting trials
25
US states with sites
2
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 2 2

Drugs and treatments being studied

InterventionTrials
ABT-8881
AGX1011
AMG 386 and Trastuzumab1
AMG 386 with or without Trastuzumab1
AMG 479 (Ganitumab) plus Metformin1
ARV-4711
ARV-471 + Abemaciclib1
ARV-471 + Letrozole1
ARX7881
ARX788 + Cemiplimab1
Amcenestrant1
Amcenestrant + Abemaciclib1

Where trials are recruiting (top US states)

StateRecruiting trials
California2
Florida2
New Jersey2
New York2
Tennessee2
Texas2
Virginia2
Alabama1
Arizona1
Colorado1
Connecticut1
District of Columbia1

Top cities

Los Angeles, California 2Nashville, Tennessee 2New York, New York 2Atlanta, Georgia 1Aurora, Colorado 1Basking Ridge, New Jersey 1Birmingham, Alabama 1Buffalo, New York 1Chicago, Illinois 1Cleveland, Ohio 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Angiosarcoma often also study these conditions. Each links to its own recruiting-trial list.

Breast cancer 2239Kaposi Sarcoma 12Colorectal cancer 1359Advanced Cancer 25Urachal Cancer 3TNBC - Triple-Negative Breast Cancer 35Soft Tissue Sarcoma 14Refractory Cancer 6Prostate cancer 1234Pancreatic cancer 870

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Angiosarcoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.